Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study

BACKGROUND/AIMS: Selenium (Se), an antioxidant agent, is effective in preventing mild Graves’ orbitopathy (GO) deterioration. However, the significant risk of low serum Se concentration for GO progression has not been identified. Here, we aimed to investigate the risk of relative Se insufficiency an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumyongsatien, Mingkwan, Bhaktikamala, Unnkade, Thongtong, Pennung, Sintuwong, Sunisa, Nimitwongsakul, Ornvenus, Kanokkantapong, Jugchawin, Pongpirul, Krit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Orbit and Oculoplastics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112433/
https://www.ncbi.nlm.nih.gov/pubmed/34041363
http://dx.doi.org/10.1136/bmjophth-2021-000713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112433/
https://www.ncbi.nlm.nih.gov/pubmed/34041363
http://dx.doi.org/10.1136/bmjophth-2021-000713

Ejemplares similares